Evolving management of patients treated by drug-eluting stent: prevention of late events.
SUMMARY: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2014
|
| _version_ | 1826275646732500992 |
|---|---|
| author | Niccoli, G Sgueglia, G Montone, R Roberto, M Banning, A Crea, F |
| author_facet | Niccoli, G Sgueglia, G Montone, R Roberto, M Banning, A Crea, F |
| author_sort | Niccoli, G |
| collection | OXFORD |
| description | SUMMARY: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared with BMS. However, this benefit is mainly evident in the first year of follow-up. Indeed, DES-related events may extend over this time, due to late events (late ISR and/or very late stent thrombosis). Prevention of late failure of DES may become a specific therapeutic target. |
| first_indexed | 2024-03-06T23:01:57Z |
| format | Journal article |
| id | oxford-uuid:626e9176-a3e8-44c5-aec9-45c60614c95f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:01:57Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:626e9176-a3e8-44c5-aec9-45c60614c95f2022-03-26T18:06:14ZEvolving management of patients treated by drug-eluting stent: prevention of late events.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:626e9176-a3e8-44c5-aec9-45c60614c95fEnglishSymplectic Elements at Oxford2014Niccoli, GSgueglia, GMontone, RRoberto, MBanning, ACrea, FSUMMARY: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared with BMS. However, this benefit is mainly evident in the first year of follow-up. Indeed, DES-related events may extend over this time, due to late events (late ISR and/or very late stent thrombosis). Prevention of late failure of DES may become a specific therapeutic target. |
| spellingShingle | Niccoli, G Sgueglia, G Montone, R Roberto, M Banning, A Crea, F Evolving management of patients treated by drug-eluting stent: prevention of late events. |
| title | Evolving management of patients treated by drug-eluting stent: prevention of late events. |
| title_full | Evolving management of patients treated by drug-eluting stent: prevention of late events. |
| title_fullStr | Evolving management of patients treated by drug-eluting stent: prevention of late events. |
| title_full_unstemmed | Evolving management of patients treated by drug-eluting stent: prevention of late events. |
| title_short | Evolving management of patients treated by drug-eluting stent: prevention of late events. |
| title_sort | evolving management of patients treated by drug eluting stent prevention of late events |
| work_keys_str_mv | AT niccolig evolvingmanagementofpatientstreatedbydrugelutingstentpreventionoflateevents AT sguegliag evolvingmanagementofpatientstreatedbydrugelutingstentpreventionoflateevents AT montoner evolvingmanagementofpatientstreatedbydrugelutingstentpreventionoflateevents AT robertom evolvingmanagementofpatientstreatedbydrugelutingstentpreventionoflateevents AT banninga evolvingmanagementofpatientstreatedbydrugelutingstentpreventionoflateevents AT creaf evolvingmanagementofpatientstreatedbydrugelutingstentpreventionoflateevents |